KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer

Published:2020-10-14 Issue:2 Volume:185 Page:343-357
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Zhou Mei,Venkata Prabhakar Pitta,Viswanadhapalli Suryavathi,Palacios Bridgitte,Alejo Salvador,Chen Yihong,He Yi,Pratap Uday P.,Liu Junhao,Zou Yi,Lai Zhao,Suzuki Takayoshi,Brenner Andrew J.,Tekmal Rajeshwar R.,Vadlamudi Ratna K.,Sareddy Gangadhara R.^ORCID

Funder

Bank of America Foundation

Max and Minnie Tomerlin Voelcker Fund

Elsa U. Pardee Foundation

National Institutes of Health

Cancer Prevention and Research Institute of Texas

Mays Cancer Center Support Grant

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-020-05963-1.pdf

Reference55 articles.

1. Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13(11):674–690. https://doi.org/10.1038/nrclinonc.2016.66

2. Sharma P (2016) Biology and management of patients with triple-negative breast cancer. Oncologist 21(9):1050–1062. https://doi.org/10.1634/theoncologist.2016-0067

3. Palma G, Frasci G, Chirico A, Esposito E, Siani C, Saturnino C, Arra C, Ciliberto G, Giordano A, D'Aiuto M (2015) Triple negative breast cancer: looking for the missing link between biology and treatments. Oncotarget 6(29):26560–26574. https://doi.org/10.18632/oncotarget.5306

4. Garrido-Castro AC, Lin NU, Polyak K (2019) Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov 9(2):176–198. https://doi.org/10.1158/2159-8290.Cd-18-1177

5. Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363(20):1938–1948. https://doi.org/10.1056/NEJMra1001389

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer;Molecular Carcinogenesis;2024-07-11

2. Epigenetic modulators provide a path to understanding disease and therapeutic opportunity;Genes & Development;2024-06-01

3. Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification;Biomedicine & Pharmacotherapy;2024-05

4. Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer;Journal of Advanced Research;2024-04

5. The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer;International Journal of Molecular Sciences;2024-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3